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Alcalá, Alcalá de Henares, Madrid, España, 3 Departamento de Biologı́a de Sistemas, Universidad de Alcalá,
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Abstract
During diabetes, renal proximal tubular cells (PTC) are exposed to a combination of high
glucose and hypoxic conditions, which plays a relevant role in the development of diabetic
kidney disease (DKD). In this work, a time-series proteomic study was performed to analyse
the effect of a diabetic-like microenvironment induced changes on HK-2 cells, a human cell
line derived from normal proximal tubular epithelial cells. Cells simultaneously exposed to
high glucose (25 mM) and hypoxia (1% O2) were compared to cells in control conditions for
up to 48 h. Diabetic conditions increased the percentage of death cells after 24 and 48 h, but
no differences in the protein/cell ratio were found. The relative protein quantification using
dimethyl-labeling and UHPLC-MS/MS analysis allowed the identification of 317, 296 and
259 proteins at 5, 24 and 48 h, respectively. The combination of statistical and time expres-
sion profile analyses indicated an increased expression of proteins involved in glycolysis,
and a decrease of cytoskeletal-related proteins. The exposure of HK-2 cells to high glucose
and hypoxia reproduces some of the effects of diabetes on PTC and, with the limitations
inherent to in vitro studies, propose new mechanisms and targets to be considered in the
management of DKD.
Introduction
Proteins are key players in many biological processes and cellular signaling events, and the
alteration of their abundancy can lead to the development of life threatening diseases [1]. It is
also known that many proteins respond to different stimuli changing their expression in a
time-dependent manner; therefore, protein expression monitoring over time is important to
understand the mechanisms behind these diseases’ development. For protein identification
and quantification, high-performance liquid chromatography coupled to mass spectrometry
(HPLC-MS) has become a key technology due to its unbiased capacity where there is no need
to decide which proteins to target in advance, and because thousands of proteins can be
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monitored at the same time and remarkable biological information can be accessed [2]. Dia-
betic kidney disease (DKD) is the most common cause of end-stage renal disease and it devel-
ops in approximately 40% of patients with diabetes [3]. Despite this fact, the pathological
mechanisms leading to the development and progression of DKD remain poorly understood,
and proteomics studies can help shedding some light. It has been demonstrated that increased
blood concentrations of glucose and non-esterified fatty acids in diabetes are intracellularly
reflected in the kidney, particularly in proximal tubules [4]. It is also evident that the proximal
tubule is a prime mover in DKD so that it plays a critical role in the development and progres-
sion of DKD [5, 6]. In diabetes, high glucose (HG) content in proximal tubule cells (PTC)
results from both increased glucose in plasma and also from excess glucose filtered by the glo-
meruli, resulting in an excessive glucose load in the tubule [5]. However, although a HG
microenvironment is the primary causative factor for the development of DKD, hypoxia also
plays a relevant role in the development and progression of this pathology [6–8]. This is partic-
ularly true for proximal tubules because they are especially vulnerable to hypoxia, and because
PTC are propense to hypoxic injury in diabetes due to three relevant factors: i) diabetes
increases two high energy consuming processes, namely gluconeogenesis and sodium reab-
sorption driven by Na+/K+-ATPase, in PTC (only their Na+/K+-ATPase consumes in basal
conditions 80% of the O2 kidney supply) [9]; ii) diabetes leads to impaired O2 utilization
because it induces mitochondrial dysfunction and alters substrate delivery in PTC; iii) diabetes
reduces O2 delivery to PTC due to microvascular rarefaction [6].
Among others, the hypoxia inducible factor-1α (HIF-1α) protein orchestrates cellular adap-
tive responses to combat hypoxia, through the expression control of several proteins [10].
However, activation of the HIF system in the hypoxic diabetic kidney has been shown to be
suboptimal [7, 11, 12] or even inexistent [8]. This may explain the renoprotective effect in
DKD of HIF-1α activation by CoCl2 [8, 13] as well as the fact that a Pro582Ser polymorphism,
which confers relative resistance of HIF-1α to the repressive effect of HG, is associated with
DKD protection [14]. Activation of the HIF system under hypoxia has also been found to be
consistently supressed by HG in PTC [15], and this deficient response seems to be specific for
PTC: HIF-1α expression in primary human mesangial cells increased under hypoxia, but a fur-
ther increase in its expression was observed when these cells were simultaneously exposed to
HG and hypoxia [16]. On the other hand, human PTC and HeLa cells did not respond to HG,
and in mouse MC, HIF-1α was induced by HG under normoxic conditions, whereas in mouse
PTC, that response was absent. In the same way, glucose promotes in cancer cells the expres-
sion of HIF-1α [17]. We have previously set up an in vitro model of diabetes-induced proximal
tubular dysfunction in which HK-2 cells, a human cell line derived from normal proximal
tubular epithelial cells, are exposed to a diabetic-like microenvironment consisting of HG (25
mM) and hypoxia (1% O2). In these conditions, HIF-1α fails to stabilize and accumulate in
HK-2 cells (i.e. the same defective response found in the hypoxic diabetic kidney) [18]. Fur-
thermore, impaired HIF-1α regulation in cells exposed to hyperglycemic, hypoxic diabetic-
like milieu led to diminished production of vascular endothelial growth factor-A and inhibi-
tion of cell migration (responses respectively involved in tubular protection and repair). These
effects, as well as impaired HIF-1α regulation, were reproduced in normoglycemia in HK-2
cells incubated with microparticles released by HK-2 cells exposed to hyperglycemic, hypoxic
diabetic-like milieu [18]. Finally, neither HG alone nor hypoxia alone affected the migration of
HK-2 cells [18] and the release of microparticles under hyperglycemia was greatly diminished
in the absence of hypoxia (unpublished results). In summary, HK-2 cells exposed simulta-
neously to hyperglycemia and hypoxia (i.e. two major conditions of the microenvironment
that surrounds proximal tubular cells in diabetes)-but not HK-2 cells exposed separately to
either condition- show functional alterations that reproduce some specific effects of diabetes
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on proximal tubular cells. Given that the monitorization of untargeted protein evolution in
HK-2 under hyperglycemic/hypoxic conditions is currently unknown, in the present work we
have conducted a shotgun time-series proteomic study based on UHPLC-MS/MS together
with stable isotope dimethyl labeling (DML) to relatively quantify the changes in protein
expressions over time. The results obtained propose new mechanisms and targets to be investi-
gated in the future for a better understanding of DKD.
Materials and methods
Chemicals and reagents
All reagents herein used were of analytical grade or higher. Acetic acid (AA), ACN, acetone,
ethyl-acetate, methanol and urea were obtained from Scharlau (Barcelona, Spain). Formic acid
(FA) was from Fisher Scientific (Geel, Belgium). Ammonia solution and NaCl were obtained
from Merck (Darmstadt, Germany). β-glycerophosphate, DTT, EDTA, formaldehyde (CH2O)
(37%, v/v), iodoacetamide (IAA), n-octyl-β-d-glucopyranoside (BOG), PBS, protease inhibitor
cocktail, sodium cyanoborohydride (NaBH3CN), sodium fluoride (NaF), sodium metavana-
date (NaVO4), tributylphosphate, triethylammonium bicarbonate (TEAB) and TFA were pur-
chased from Sigma-Aldrich (St. Louis, MO). Trypsin/Lys-C mix (Mass Spec grade V5072) was
purchased from Promega (Madison, WI), deuterated formaldehyde (CD2O) (20%, v/v) was
obtained from ISOTEC (Miamisburg, OH) and sodium pyrophosphate from Alfa Aesar (Kan-
del, Germany). Ultrapure water was prepared by Milli-Q water purification system (Millipore,
Bedford, MA).
Cell culture conditions
Human proximal tubular epithelial (HK-2) cells were purchased from the American Type Cul-
ture Collection (Rockville, MD, USA). HK-2 cells were maintained in DMEM/F12 (Thermo-
Fisher, Grand Island, NY, USA) supplemented with 10% FBS, 1% penicillin/streptomycin/
amphoterycin B, 1% glutamine and 1% insulin-transferrine-selenium (ITS) (ThermoFisher,
Grand Island, NY, USA). One week before the beginning of the experiments, cell culture
medium was changed to DMEM normal glucose (NG, 5.5 mM glucose, ThermoFisher, Grand
Island, NY, USA) supplemented as stated above. Cells were routinely maintained in 21% O2
(normoxic conditions) at 37 ˚C. To perform the experiments, seven p35 cultured plates were
seeded with 2.5 x 105 cells (90% confluence) per time and treatment condition. When
completely attached, cells were exposed to either medium DMEM NG or DMEM high glucose
(HG, 25 mM glucose, ThermoFisher, Grand Island, NY, USA) supplemented with 0.5% FBS,
1% penicillin/streptomycin/amphoterycin B, 1% glutamine and 1% ITS under hypoxic (1%
O2) or normoxic conditions (21% O2), for 5, 24 and 48 h. For 48 h experiments, cell culture
medium was refreshed at 24 h. Hypoxia experiments were performed in an In vivo200 hypoxia
workstation (Ruskinn Technology, West Yorkshire, UK). Cells were manipulated and lysed
inside the chamber, and all media and buffers were pre-equilibrated to 1% O2. Three replicates
were used to determine the total cell number and the cell viability based on the Trypan Blue
dye exclusion assay, and a hemocytometer. Briefly, cells were detached by trypsinization and,
together with the detached cells recovered from the culture medium, they were stained with
Trypan Blue (1:1). Then, white (viable) and blue (dead) cells were counted using a light micro-
scope and a hemocytometer. For the proteomic study, and after incubation, the growth
medium from three culture plates was removed by aspiration, washed with PBS, and proteins
were directly extracted from attached cells. An additional plate per time and treatment condi-
tion was used to check by Western blot analysis the interaction between HG and hypoxia
resulting in specific loss of hypoxia-induced accumulation of HIF-1α in HK-2 cells [18].
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Statistical analysis was performed using Statistica software version 7.1 (StatSoft, Inc., USA).
One-way ANOVA with LSD Post-hoc test was employed to determine any significant differ-
ences between mean values using p< 0.05.
Sample preparation for UHPLC–MS/MS-based proteomics
Cells were lysed with 300 μL of lysis buffer (6 M urea, 1% (m/v) BOG, 0.15 M NaCl, 1.3 mM
EDTA, 1 mM NaVO4, 5 mM NaF, 2.5 mM sodium-pyrophospate, and 5 mM β-glyceropho-
sphate in PBS) supplemented with 10 μL of protease inhibitor cocktail to prevent protein deg-
radation. The samples were incubated for 60 min at 4 ˚C, sonicated for 30 min at 0 ˚C in a
water bath, and then centrifuged at 10000g at 4 ˚C for 15 min. The supernatants were collected,
and protein concentration was quantified using Bradford assay (Bio-Rad Laboratories, Hercu-
les, CA). 20 μg of proteins were mixed with 500 μL of an ice-cold tributylphosphate/acetone/
methanol mixture (1:12:1, v/v/v) and incubated at 4 ˚C for 90 min (mixing every 15 min). The
precipitate was centrifuged for 15 min (3000g at 4 ˚C), washed with 1 mL of cold acetone, and
air-dried. Pellets were dissolved in 20 μL of 1% (w/v) BOG with 20% (v/v) ACN in 0.1 M
TEAB, and the proteins were reduced with 10 μL of 45 mM DTT at 56 ˚C for 15 min, cooled
down to room temperature and alkylated with 10 μL of 100 mM IAA for 15 min in the dark.
Samples were then digested with 0.5 μg of LysC/trypsin solution (5% (w/w), of total protein
content) and incubated at 37 ˚C overnight in darkness. The digests were dried to remove ACN
and resuspended in 70 μL of 0.1 M TEAB, and BOG was extracted with water-saturated ethyl-
acetate [19]. Dimethyl labelling was performed according to Boersema et al [20]. Briefly, tryp-
tic peptide mixtures were reconstituted in TEAB and NG-Normoxia samples were labelled as
light (L) using regular formaldehyde (CH2O, 4% (v/v)), and HG-Hypoxia samples were
labelled as medium (M) using deuterated formaldehyde (CD2O, 4% (v/v)). Technical replicates
were included for each sample in a swap-labelling experiment form (NG-Normoxia samples
labelled as M, and HG-Hypoxia samples labelled as L). To control the labelling efficiency and
optimize the UHPLC peptide loading quantity and MS parameters, 120 μg of NG-Normoxia
samples were divided into six aliquots of 20 μg, and three aliquots were labelled as L, and the
other three as M, following the same procedure as explain above. These samples were consid-
ered as “Test” samples. After a brief vortexing, 4 μL of freshly prepared 0.6 M NaBH3CN solu-
tion was added to each sample, and the vials were incubated for 60 min at room temperature
with mild agitation. The reaction was terminated by adding 1% (v/v) ammonia solution
(Merck, Germany), and 5% (v/v) FA (Merck, Germany) to consume the excess labelling
reagents. Finally, the real samples labelled as L and M were mixed together and for the “Test”
samples, one L sample and one M sample were mixed together, generating 3 “Test” samples.
All mixed samples were desalted on Isolute C18 solid-phase extraction columns as specify by
the manufacture (1 mL, 50 mg capacity, Biotage, Uppsala, Sweden). After being desalted, pep-
tides were dried in a SpeedVac and redissolved in 2% (v/v) ACN and 0.1% (v/v) TFA prior to
UHPLC–MS/MS analysis. Two replicates were analysed for each “Test” condition, and six rep-
licates (considering biological and technical replicates) were analysed for the real samples at
each time point, giving a total of 18 LC-MS/MS runs.
UHPLC–MS/MS analysis
Aliquots of 5 μL containing * 1, 2, 4 or 6 μg (for “Test” samples), or* 6 μg (for real samples)
tryptic peptides were injected into a LC–MS/MS system consisting of an UltiMate 3000 quater-
nary UHPLC (Thermo Fisher Scientific, Bremen, Germany) coupled to a Q Exactive Pro Mass
Spectrometer (Thermo Fisher Scientific, Bremen, Germany) using a HESI-II probe at 3 kV.
Peptide separations were performed on a C18 Ascentis Express column (Sigma, St Louis,
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USA), having 100 × 2.1 mm i.d. dimensions (fused-core1 particles with 0.5 μm thick porous
shell and an overall particle size of 2.7 μm), and a guard column (5 × 2.1 mm i.d. × 2.7 μm par-
ticle size) of the same composition as the analytical columns. Columns were kept at 55˚C dur-
ing the analysis of the samples. The separations were performed at a flow rate of 0.3 mL/min
with mobile phases A (2% (v/v) ACN, 0.3% (v/v) AA, 0.1% (v/v) FA) and B (80% (v/v) ACN,
0.3% (v/v) AA, 0.1% (v/v) FA). A 60 min gradient from 0.2% B to 46.2% B was used. The mass
spectrometer was operated in positive-ion mode and a Top6 data-dependent acquisition
(DDA) mode was used. MS1 spectra were acquired within m/z 350–1600 with an automatic
gain control (AGC) of 3 x 106 at 35,000 resolution and with a maximum ion time (IT) of 110
ms. Up to 6 of the most abundant precursor ions with�2 and�8 charges and threshold inten-
sity of 2 x 104 were selected for higher-energy C-trap dissociation (HCD). An isolation window
of 2 m/z and normalized collision energy of 28 were used. Ions that were once selected for
acquisition were dynamically excluded for 20 s for further fragmentation. MS2 spectra were
acquired with an AGC of 1 x 105 at resolution of 35,000 and a maximum IT of 110 ms. A
Top12 DDA mode was also tested, keeping the MS1 parameters as for the Top6 but increasing
the number of precursor ions to 12, and acquiring the MS2 spectra with an AGC of 1 x 105 at
resolution of 17,500 and a maximum IT of 50 ms.
MaxQuant analysis
All MS raw files were collectively processed with MaxQuant (version 1.6.3.3) [21] using the
Andromeda search engine [22]. The FDR was set to 1% for both proteins and peptides, and a
minimum of two peptides with at least seven amino acid length was specified. MaxQuant
scored peptides for identification based on a search with a maximal precursor mass deviation
of 20 ppm (first search) and 4.5 ppm (main search), and fragment masses deviations of up to
20 ppm. The Andromeda search engine was used for the MS/MS spectra search against a
concatenated forward and reversed version of the Uniprot human database (downloaded on
April 24th, 2019 and containing 20,428 entries). Trypsin was selected as digestive enzyme and a
maximum of two missed cleavages were allowed. Carbamidomethylation of cysteine residues
was set as the fixed modification, and the oxidation of methionine and protein N-acetylation
were set as variable modifications. For dimethyl labeling, DimethylLys0 and DimethylNter0
were set as light labels, and DimethylLys4 and DimethylNter4 were set as medium labels. A
minimum peptide ratio count of two and at least one “razor peptide” was required for quantifi-
cation. All mass spectrometry proteomics data and search results have been deposited to the
ProteomeXchange Consortium via the PRIDE [23] partner repository with the data set identi-
fier PXD015102.
Database search/data processing
Prior to any statistical analysis, identifications flagged as reverse, potential contaminants, or
proteins identified only by site modification were excluded for further analysis, and the nor-
malized relative protein abundance was transformed to the log2 scale. For PCA, only proteins
present in all biological and technical replicates across the three time points were considered
to avoid imputation of missing values. Thereafter, the values were normalized (subtracting the
mean value of each data set and dividing by its standard deviation), and the temporal profiles
were clustered using the fuzzy c-means clustering algorithm included in the Mfuzz tool-
box [24]. Different combinations of cluster sizes and fuzzification parameters were explored
and found optimal partitioning with c = 6 and m = 3. The lists of proteins with Euclidean dis-
tance larger than 0.5 in each cluster were searched for enriched gene ontology (GO) terms or
pathways using the web-based PANTHER (http://www.pantherdb.org/) [25] or STRING [26].
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The corrected p-values were derived from a Fisher’s Exact test followed by Benjamini and
Hochberg false discovery rate correction, and considered significant when < 0.05. Thereafter,
the most significantly altered proteins between hypoxia/hyperglycemia against normoxia/nor-
moglycemia were identified. For this analysis, a protein was included in the analysis when it
was quantified in at least four sample replicates at the different time points. In these cases, a
p value of< 0.05 (after one sample t-test) and a 1.2-fold change cut-off filter (equivalent to
0.26 and -0.26 in log2 scale) were applied. Finally, the list of significantly altered proteins at
48 h was searched for enriched GO biological processes using PANTHER and STRING soft-
wares using the same parameters as previously specified.
Results
Cell viability and protein content
The main objective of this work was to carry out a time-course proteomic study to investigate
the changes induced by a diabetic-like hyperglycemic/hypoxic medium in HK-2 cells, a cell
line derived from human proximal tubular cells, as an in vitro model of the effects of the
diabetic milieu on proximal tubular cells in the context of DKD. For this study, equal number
of cells (5 × 105 per mL) were plated at 90% confluence in p35 cultured dishes and when
completely attached, they were treated for 5, 24 and 48 h with HG (25 mM) medium in hyp-
oxic conditions (1% O2), or with NG medium (5.5 mM) in normoxic conditions (21% O2).
The interaction between HG and hypoxia resulting in specific loss of hypoxia-induced accu-
mulation of HIF-1α in HK-2 cells, which has important pathological implications in the con-
text of proximal tubular disfunction in DKD [18], was routinely checked (results are not
shown).
While the percentage of death cells increased from 7% to 12% after 24 h in HG-Hypoxia
compared to NG-Normoxia, and rose up to more than 20% after 48 h (Fig 1A), no differences
Fig 1. Percentage of dead cells (A) and protein content/cell (B) after incubation of HK-2 cells in NG (5.5 mM glucose)-normoxia
(21% O2) or HG (25 mM glucose)-hypoxia (1% O2). Error bars are given as the standard deviation of three independent experiments.
�Asterisks indicate significant differences between samples after ANOVA with LSD Post-hoc, p-value< 0.05.
https://doi.org/10.1371/journal.pone.0235118.g001
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in the protein/cell ratio between the two experimental groups were found at any time point
(Fig 1B).
Peptide loading quantity and MS acquisition
The proteomic study was performed using preliminary UHPLC and MS conditions as previ-
ously reported by Lenčo et al. [27] and some parameters were then optimized. Firstly, the
UHPLC peptide loading quantity was optimized based on the total number of identified/quan-
tified proteins after loading 1, 2, 4 and 6 μg of the peptides from the “Test” samples, and the
labelling efficiency was checked (Table 1). As shown in this table, the number of identified/
quantified proteins increased when more peptides were injected, and the use of the Top6 MS
acquisition method allowed the quantification of more than 270 proteins after the injection of
6 μg. Secondly, a Top12 MS acquisition method was evaluated injecting 6 μg of proteins,
which did not improve the results obtained using the Top6 method. Moreover, the variability
for the protein quantification was similar for all the preparations, indicating that the peptide
labelling was adequate. Compared to the work carried out by Lenčo et al. [27] a lower number
of quantified proteins was expected as those authors used a faster mass spectrometer and a
smaller inner diameter analytical column, which decreases the sample dilution and increases
the number of identified proteins. However, they did not quantify and only identified proteins,
without specifying the number of peptides used for this identification. In the present study, a
restrictive criterion was applied and proteins were identified when at least two peptides
belonging to each protein were detected. In addition, a minimum peptide ratio count of two
was selected for protein quantification, which means that two peptides for each labelled sample
were needed. Despite the fact that the total number of quantified proteins could be increased if
more peptides/proteins are injected, the protein quantity was set to 6 μg to analyse the real
samples to avoid column overloading and to prevent MS instrument contamination.
Overview of the temporal expression protein changes
Based on the above information, 6 μg of peptides were injected and the Top6 MS method was
selected to study the effect of HG-Hypoxia against NG-Normoxia over time. After applying a
FDR of 1%, a total number of 526 proteins were identified, with an average of 317 ± 64,
296 ± 25 and 259 ± 54 proteins at 5, 24 and 48 h, respectively (Table 2 and S1 Table). In addi-
tion, a total of 150 proteins were simultaneously quantified in all biological and technical repli-
cates, and a PCA multivariate analysis was carried out to determine, compare and visualize the
overall relation between the three conditions studied (Fig 2). This analysis indicates that the
combination of the two main components captured almost 40% of the variance of the data,
being the principal component 1 the one that clearly separates and groups together the samples
representing 5, 24 and 48 h.
Table 1. Loaded peptide quantity, MS detection method, identified/quantified proteins and average quantified proteins in HK-2 cells after UHPLC-Orbitrap-MS/
MS analysis.
Loaded Peptide Quantity (μg) MS Method Identified proteins Quantified proteins Protein quantification Average ± SD Ratio
1 Top6 51 ± 2 32 ± 1 0.93 ± 0.13
2 Top6 131 ± 5 81 ± 4 0.97 ± 0.18
4 Top6 265 ± 4 188 ± 4 0.96 ± 0.14
6 Top6 321 ± 1 278 ± 4 0.96 ± 0.15
6 Top12 207 ± 1 137 ± 4 0.96 ± 0.16
https://doi.org/10.1371/journal.pone.0235118.t001
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Thereafter, the expression of the same 150 proteins used for PCA were searched for patterns
in their time expression profiles using the fuzzy c-means clustering algorithm. This algorithm
does not establish a protein expression cut-off filter, but it measures the expression similarity
(based on the distance, connectivity, and intensity) between the different proteins across the
time, and then groups those proteins accordingly. It has to be noted that each protein can
belong to more than one cluster. Using this software, the proteins were clustered in six profiles,
containing between 6 and 24 proteins (Fig 3). In the figure, each trace corresponds to a pro-
tein, and the colour is coded according to its membership value for the respective cluster
Table 2. Number of quantified proteins after the incubation of HK-2 cells in NG-Normoxia and HG-Hypoxia
conditions.
Parameter 5 h 24 h 48 h
Proteins in NG-Normoxia (L)/HG-Hypoxia (H) 315 277 250
Proteins in HG-Hypoxia (L)/NG-Normoxia (H) 319 314 269
Average proteins (considering 6 replicates) 317 296 259
Proteins simultaneously quantified in all replicates 150
Proteins simultaneously quantified in at least four replicates 286 282 243
Proteins in at least four replicates with p-val� 0.05 35 60 59
Up-regulated proteinsa 2 3 14
Down-regulated proteinsb 2 8 13
a p-val� 0.05 and log2 fold change� 0.26 between HG-Hypoxia vs NG-Normoxia.
b p-val� 0.05 and log2 fold change� -0.26 between HG-Hypoxia vs NG-Normoxia.
https://doi.org/10.1371/journal.pone.0235118.t002
Fig 2. Principal component analysis of the 150 quantified proteins in all biological and technical replicates across
the three time points (5, 24 and 48 h) in HK-2 cells treated with HG (25 mM glucose)-hypoxia (1% O2) in
comparison to NG (5.5 mM glucose)-normoxia (21% O2). The first number after the different time points indicates
the biological replicate, and the second number indicates the technical replicate.
https://doi.org/10.1371/journal.pone.0235118.g002
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(higher values indicate higher similarity to the stablished profile). The proteins in each cluster
were then analysed (by functional enrichment analyses) to identify overrepresented GO term
and pathways using PANTHER (S2 Table) and STRING (S3 Table) softwares. The proteins
considered in cluster 1 (with decreased expression between 5 h and 24 h, but slightly increased
Fig 3. Time-course protein profiles obtained by fuzzy c-means clustering in HK-2 cells treated with HG (25 mM glucose)-
hypoxia (1% O2) in comparison to NG (5.5 mM glucose)-normoxia (21% O2) at 5, 24 and 48 h. The y axis is log10 transformed
and normalized, and the number of proteins considered in each cluster is given in parentheses. Each trace is colour coded according
to its membership value for the respective cluster (see colour bar).
https://doi.org/10.1371/journal.pone.0235118.g003
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between 24 and 48 h) are involved in the translational initiation biological process as some
proteins are structural constituent of ribosome. In cluster 2, the protein expression dramati-
cally increased between 5 h and 24 h and then it slightly decreased between 24 and 48 h. These
proteins are involved in several terms, but the main molecular function is the RNA binding.
The expression of proteins considered in cluster 3 decreased between 5 h and 24 h, but it dra-
matically increased between 24 and 48 h. These proteins are involved in the broad molecular
functions RNA binding and processing. Cluster 4 was the one with the highest number of pro-
teins (24), which abundance continuously increased from 5 to 48 h. These proteins are
involved in several biological processes (glycolytic process, ATP generation from ADP, pyru-
vate biosynthetic process, NADH regeneration, canonical glycolysis), in the Glycolysis/Gluco-
neogenesis pathways (ENO1, PKM, PGAM1, ALDOA, TPI1, PGK1 and GAPDH) or in the
HIF-1 signaling pathway. On the other hand, proteins represented in cluster 5 were highly
abundant at 5 h, and their expression constantly decreased with time, being minimal at 48 h.
These proteins are involved in the actin-dependent ATPase activity, they are structural
constituents of cytoskeleton, or they belong to the ubiquitin-like protein ligase binding, the
cadherin binding, or the identical protein binding molecular functions. Some of them also
form part of different pathways such as the Cytoskeletal regulation by Rho GTPase. Finally,
the expression of proteins in cluster 6 was constant between 5 and 24 h, but it decreased after
48 h. These proteins form part of the structural molecule activity and the RNA binding func-
tions, and in the Eukaryotic Translation Elongation pathway. In summary, this analysis con-
fers an overview of the protein expression profiles and the functions in which the proteins are
involved, without losing the information of proteins with small but similar expression
patterns.
Significantly altered proteins at specific time points
In addition to the multivariate and the temporal expression analyses, the most significantly
altered proteins between HG-Hypoxia and NG-Normoxia at each specific time point were
identified. For this analysis, several filtering criteria were applied (Table 2). Firstly, a protein
was selected for further processing when it was identified in at least four sample replicates at
the different time points. Taking into account this filtering criteria, 286, 282 and 243 proteins
were quantified at 5, 24 and 48 h respectively. Secondly, a p-value cut-off filter <0.05 after one
sample t test analysis was applied, and among the proteins quantified at each time point, 35, 60
and 59 passed this criteria at 5, 24 and 48 h, respectively. Finally, and to identify the most sig-
nificantly altered proteins, a 1.2-fold change cut-off filter (equivalent to 0.26 and -0.26 in log2
scale) was applied and only 4, 11 and 27 proteins (at 5, 24 and 48 h, respectively) passed this
criteria. The full list of proteins and their expression values are shown in (Table 3). Addition-
ally, the list of significantly altered proteins at 48 h was searched for enriched GO biological
processes using PANTHER and STRING softwares, and the results are shown in Table 4 and
Fig 4. The results show that the expression of two ribosomal proteins was decreased (RPL18,
RPL34) while the expression of two histone subunits was increased (HIST1H3A, HIST1H4A)
after 5 h of treatment. After 24 h, the expression of three additional ribosomal-related proteins
was decreased (RPS27, RPL28, UBA52), as well as the expression of different cytoskeletal-
related proteins (CNN2, STMN1, TPM1), or other proteins (FN1, STAT1). On the other hand,
the levels of two proteins involved in the glycolysis pathway were increased (GPI, LDHA), as
well as the rate-limiting enzyme implicated in the reduction of glucose to sorbitol via the
polyol pathway (AKR1B1). At 48 h, the levels of two histone subunits already were observed as
increased at 5 h (HIST1H3A and HIST1H4A), and the levels of the subunit HIST1H1B, were
observed as decreased, while the expression of some proteins observed as decreased at 24 h,
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decreased even more (FN1, STAT, STMN1). Moreover, the expression of three additional
cytoskeletal related proteins were observed as decreased (TMSB4X, TPM4, TUBB), as well as
the proteasome subunit PSME1, the ADP/ATP Translocase 2 (SLC25A5) and the ATP
Synthase F1 Subunit Beta (ATP5B). On the other hand, most of those proteins with positive
ratios are involved in the glycolysis pathway (ALDOA, GAPDH, GPI, LDHA, PGAM1, PGK1,
PKM, TPI1), or they are associated with the endoplasmic reticulum (RTN4, HSPA1B,
HSPH1). Finally, the expression of AKR1B1 was observed as increased, being its expression
higher than at 24 h.
Table 3. Significantly altered proteins after the incubation of HK-2 cells with HG-Hypoxia in comparison to NG-Normoxia for 5, 24 and 48 h.
5 h 24 h 48 h
Gene name log2FC N˚ samples p-value log2FC N˚ samples p-value log2FC N˚ samples p-value
AKR1B1 -0.13 6 1.9E-03 0.27 6 1.2E-02 0.52 6 2.0E-03
ALDOA -0.01 6 5.7E-01 0.25 6 1.2E-05 0.45 6 4.9E-04
ATP5B -0.10 6 2.7E-01 -0.12 6 9.4E-02 -0.29 6 2.2E-02
CNN2 -0.11 6 1.8E-01 -0.27 6 1.2E-03 -0.46 2 3.6E-01
EZR 0.03 6 5.7E-01 0.08 6 1.3E-01 0.36 6 6.8E-04
FN1 -0.03 6 2.6E-01 -0.65 6 5.9E-04 -0.92 6 6.7E-07
FUS -0.02 6 6.4E-01 -0.02 6 4.6E-01 0.30 5 1.3E-03
GAPDH -0.01 6 7.4E-01 0.07 6 1.1E-01 0.27 6 1.1E-02
GPI -0.09 6 7.5E-02 0.28 6 5.0E-03 0.46 5 2.7E-03
HIST1H1B 0.03 6 5.7E-01 -0.09 6 2.3E-01 -0.49 5 1.1E-02
HIST1H3A 0.58 6 4.7E-02 -0.11 6 2.5E-01 -0.66 6 1.1E-03
HIST1H4A 0.60 6 4.0E-02 -0.11 6 1.7E-01 -0.57 6 9.7E-03
HSPA1B 0.22 6 4.1E-04 0.23 6 1.6E-04 0.37 6 4.0E-04
HSPH1 -0.08 2 2.7E-01 0.53 2 1.3E-01 0.75 4 2.7E-04
LDHA -0.01 6 9.1E-01 0.43 6 1.5E-05 0.85 6 1.5E-05
PGAM1 -0.01 6 7.0E-01 0.18 6 4.0E-03 0.40 6 5.0E-04
PGK1 -0.04 6 2.0E-01 0.23 6 7.0E-05 0.60 6 4.0E-05
PKM -0.03 6 1.3E-01 0.12 6 2.2E-03 0.28 6 2.9E-03
PSME1 0.03 6 7.2E-01 -0.10 6 5.3E-02 -0.29 4 1.5E-02
RPL18 -0.30 6 6.3E-03 -0.22 6 3.9E-02 0.02 5 7.4E-01
RPL28 -0.30 2 1.4E-01 -0.40 6 7.6E-03 -0.37 5 1.2E-01
RPL34 -0.34 6 2.0E-04 -0.14 6 3.3E-02 -0.01 6 9.0E-01
RPS27 0.10 6 4.4E-01 -0.36 4 3.4E-02 -0.04 3 8.8E-01
RTN4 -0.01 6 8.6E-01 0.14 6 1.2E-01 0.37 5 1.7E-02
S100A6 0.01 6 9.1E-01 -0.18 6 7.6E-02 -0.30 6 1.5E-05
SLC25A5 0.15 6 1.4E-02 -0.03 6 5.5E-01 -0.33 6 8.9E-03
STAT1 0.05 6 1.8E-02 -0.29 6 9.0E-04 -0.79 6 1.4E-06
STMN1 -0.14 6 1.7E-01 -0.26 6 4.7E-04 -0.70 6 4.3E-03
TMSB4X 0.09 6 5.8E-01 -0.18 6 2.2E-02 -0.40 6 1.7E-03
TPI1 -0.05 6 8.7E-02 0.21 6 9.6E-06 0.35 6 4.0E-04
TPM1 -0.13 6 1.2E-01 -0.90 4 7.8E-06 - - -
TPM4 -0.05 6 4.8E-01 -0.10 6 1.5E-01 -0.31 6 3.9E-02
TUBB -0.15 6 5.9E-03 -0.24 6 5.2E-03 -0.29 6 1.0E-03
UBA52 -0.14 6 5.2E-02 -0.33 6 6.7E-04 -0.13 6 3.8E-02
� In grey, significantly altered proteins.
https://doi.org/10.1371/journal.pone.0235118.t003
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Discussion
In this study, a UHPLC-MS method was optimized to monitor, for the first time, the protein
expression dynamics of HK-2 cells subjected to a diabetic-like microenvironment consisting
of HG (25 mM) and hypoxia (1% O2) at different time points (5, 24 and 48 h). One important
aspect when studying proteome dynamics is that changes in protein abundance depend on the
synthesis of new proteins and/or their degradation, which often requires hours/days. However,
the analysis time-frame of these in vitro proteomics studies is usually limited because the
Table 4. Overrepresented PANTHER GO biological processes after the incubation of HK-2 cells with HG-Hypoxia in comparison to NG-Normoxia for 48 h.
PANTHER GO Biological Process N˚ proteins (reference) 48 h
N˚ proteins Protein names Enrichment FDR
Glycolytic process 18 5 PGK1, ALDOA, PKM, GPI, TPI1 > 100 1.4e-07
Glucose metabolic process 25 3 PGK1, GPI, TPI1 96.24 7.1e-04
Regulation of proteasomal protein catabolic process 25 2 HSPA1B, PSME1 64.16 3.8e-02
Carbohydrate biosynthetic process 43 3 PGK1, GPI, TPI1 55.95 2.7e-03
Oxidation-reduction process 185 5 PGK1, ALDOA, PKM, GPI, TPI1 21.67 4.9e-04
Regulation of organelle organization 271 4 HIST1H1B, TMSB4X, HSPA1B, STMN1 11.84 2.7e-02
Cytoskeleton organization 587 5 TMSB4X, TPM4, HSPA1B, STMN1, TUBB 6.83 4.7e-02
https://doi.org/10.1371/journal.pone.0235118.t004
Fig 4. STRING diagram representing protein interaction pathway derived from the 27 proteins significantly
altered at 48 h after the incubation of HK-2 cells with HG-Hypoxia in comparison to NG-Normoxia. The average
local clustering coefficient as reported by STRING is 0.703. Proteins in yellow belong to the glycolytic process; proteins
in red belong to the ATP metabolic process; proteins in blue belong to the cytoskeleton organization; and proteins in
green belong to the regulation of organelle organization.
https://doi.org/10.1371/journal.pone.0235118.g004
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control of cell characteristics is commonly lost after 72 hours [28]. The present study demon-
strates that short exposure times (5 h) do not significantly affect the overall protein expression,
but this expression is significantly affected when the exposure time is sustained for 24 and 48
h, being the changes at 48 h the most remarkable.
As presented in the results section, the most significant protein changes are related to the
glycolytic pathway. It is known that oxidation of glucose in the cytosol through glycolysis leads
to pyruvate as a final product and renders only two ATP molecules (as compared to 38 ATP
molecules generated by complete oxidation of glucose via pyruvate through the tricarboxylic
acid cycle and oxidative phosphorylation). Nevertheless, the rate of glucose metabolism
through this pathway, in which oxygen is not required, is 10–100 times faster than that
through the complete aerobic oxidation of glucose in mitochondria [3]. Therefore, anaerobic
glycolysis in the hypoxic kidneys of diabetic patients might contribute to the quick metabolism
of glucose from the systemic circulation [29]. In fact, previous studies have shown that the
development of DKD is associated with increased anaerobic glycolysis in detriment of com-
plete aerobic oxidation of glucose in mitochondria [30, 31]. In this context, it is not surprising
that, in the specific conditions performed in the present study, the glycolysis pathway is the
most affected pathway over time in HK-2 cells, being increased from 5 to 48 h. The enhanced
expression of 7 glycolytic enzymes (ALDOA, ALDOB, ENO1, GAPDH, PGAM1, PKM2 and
TPI1), as well as LDHB and AKR1B1 was identified in a proteomic analysis of post-mortem
glomeruli of kidneys from diabetic patients, [31], which is highly coincident with the data
obtained in our study. This suggests that our experimental in vitro model of diabetic-like
milieu-induced protein expression changes in PTC reproduces important changes in the
expression of glucose metabolizing enzymes induced by diabetes at the renal level, and that
some of the observed changes in our setting might be beneficial adaptive responses to the dia-
betic-like microenvironment.
A previous study in db/db type 2 diabetic mice shows little coincidence with our proteomic
results. In that study, transcriptomic and metabolomics analyses also indicated that diabetes
increases the expression of several glycolytic enzymes in kidney cortex, which is 90% proximal
tubules [30], but the enzymes whose mRNA expression was significantly increased were hexo-
kinase, phosphofructokinase and pyruvate kinase (the only enzyme coincident with our
study). The little correlation between the proteomic and the transcriptomic profiles has been
previously found in cultured skin fibroblasts from type 1 diabetes patients, and suggested to
the authors that the expression of glycolytic enzymes is mainly regulated at a post-transcrip-
tional level [32]. A similar discordance between the transcriptome and the metabolome in sci-
atic nerve from db/db type 2 diabetic mice led the authors to suggest that post-transcriptional
or post-translational modifications are important in the development of diabetic nephropathy
[30]. Moreover, different transcriptomic studies of kidney biopsy samples from patients with
DKD or DN have not identified significant changes in the mRNA levels of glycolytic enzymes
[33, 34].
Besides glycolytic enzymes, other proteins whose changes might be considered as part of a
beneficial adaptive response to the diabetic-like microenvironment are STAT1 and HSPs.
Inhibition of STAT1 (as in our results), a cytosolic transcription factor, has been found to pro-
tect against tubulointerstitial injury in animal models of DKD [35,36]. On the other hand,
overexpression of several cytoprotective HSPs has been found in animal models of diabetes
[37]. In our study, expression of HSP70 isoform 1B and HSP105 in HK-2 cells was increased
along the time (being maximum at 48 h) by diabetic-like milieu. HSP105 has been shown as an
important element of the HSP70 machinery for refolding of denatured proteins and protection
against stress-induced cell death in mammalian cells [38], which suggests that overexpression
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of HSP105 and HSP70 in HK-2 cells might be a coordinated response against the cellular stress
imposed by hypoxia and hyperglycemia.
In our study, the results related with the pathogenesis of DKD can be classified in those
involving the mitochondrial reversible proton pump (F1F0-ATP synthase) and those involving
changes in the expression of fibrosis-related proteins. Regarding F1F0-ATP synthase, it is well
known that diabetes impairs kidney mitochondrial bioenergetics [39] and that decreased levels
of ATP5B have been shown to aggravate DKD [40]. Among the different enzymes involved in
the oxidative phosphorylation (OxPhos) mechanism, F1F0-ATP synthase is essential to syn-
thesize ATP in the mitochondrion, and synthesized ATP is then exported to the cytosol by the
adenine nucleotide translocase [41]. In our study, we have observed a significant decrease of
ATP5B levels at 48 h and a decrease in the expression of ATP5A1 over the time, which suggests
a shut-down of the OxPhos mechanism leading to a decrease in mitochondrial ATP. These
results agree well with previous studies in PTC in which HG exposition reduced the ATP levels
and other respiratory parameters [42, 43] or the expression of ATP synthase subunit d
(ATP5PD) [44].
With regard to the expression of fibrosis-related proteins, we did not find any increase in
the expression of extracellular matrix proteins (fibronectin was even decreased) in HK-2 cells
exposed to hypoxia/high glucose conditions. This contrasts with the generally accepted view
that deposition of extracellular matrix proteins leading to tubulointerstitial fibrosis is involved
in the pathogenesis of DKD [45] and suggests that it is required more than 48 h to increase the
expression of extracellular matrix proteins in HK-2 cells under diabetic-like conditions. This
view may be supported by the fact that we did not find either any statistically significant differ-
ence between cells incubated in control conditions and cells incubated in diabetic-like micro-
environment in the total protein/cell ratio (an index of cell hypertrophy) [46] which is
expected to be increased because PTC hypertrophy is a consequence of diabetes [47]. Con-
trarily to extracellular matrix proteins, other changes in proteins related to renal fibrosis, i.e.
cytoskeletal-related proteins [48], have been adequately detected in our experimental setting
and we speculate that the decrease in the expression of TUBB, CNN2, TPM1 and ACTB in
HK-2 cells exposed to the diabetic-like microenvironment might also occur in proximal
tubules of diabetic patients, thereby initiating cytoskeletal alterations leading to tubulointersti-
tial fibrosis. The same hypothesis applies to the decreased expression of STMN1, TMSB4X and
MYH9 in HK-2 cells under diabetic-like conditions, because: i) STMN1 is a microtubule-
destabilizing phosphoprotein [49] whose deficiency in mice has been connected to the devel-
opment of renal fibrosis [50]. In addition, STMN1 is a cell cycle regulator and its down-regula-
tion by hypoxia has been linked to renal fibrosis in HK-2 cells through G2/M cell cycle arrest
[51]; ii) TMSB4X is a potent regulator of actin polymerization with critical roles in maintain-
ing the cell cytoskeleton [52], and daily TMSB4X treatment for 3 months reduced albuminuria
and attenuated renal tubulointerstitial fibrosis in a mouse model of type 2 diabetes mellitus
[53]. TMSB4X also alleviates renal tubulointerstitial fibrosis and tubular cell apoptosis in a rat
model of tubulointerstitial fibrosis [54], and in tubular epithelial cells from a rat model of renal
fibrosis through the TGF-β pathway [55]; iii) MYH9 is an actin regulator via activation of
RhoA whose deletion in mice was associated with fibrosis and proteinuria [56]. Another cyto-
skeleton-related protein that might contribute to tubulointerstitial fibrosis in DKD is ezrin,
which links membrane proteins to the actin cytoskeleton, and whose expression increased in
HK-2 cells exposed to the diabetic-like milieu. This protein belongs to the ezrin/radixin/moe-
sin protein family that can interact with membrane and F-actin proteins [57]. Ezrin has been
suggested to contribute in PTC to the uptake by micropinocytosis of advanced glycation
end products (which results from the non-enzymatic glycation of proteins during chronic
hyperglycemia and contribute to DKD) [58] and thereby to promote diabetes-induced
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tubulointerstitial fibrosis [59]. However, further studies are needed to connect all the men-
tioned cytoskeletal-related changes with fibrosis in a mechanistic fashion.
It should be noted that our work has a number of limitations. We have found that exposure
of HK-2 cells to the diabetic-like microenvironment results in a time-dependent increase in
cell death, reaching values higher than 20% at 48 h (Fig 1A). Although the presence of some
apoptotic tubular cells in both human and experimental DKD is well stablished [60–63], exces-
sive acute cell death is not a feature of DKD. We do not know the reason of the high cell death
values found in vitro, but even higher cell death values have been found in a previous work in
which HK-2 cells or NRK-52E renal tubular epithelial cells were exposed to 30 mM glucose/
1% O2 and apoptosis was quantified [64]. Furthermore, high glucose or hypoxia separately
also induce in cultured proximal tubular cells around 15%-25% apoptotic cell death [65–70].
Thus, in DKD studies the in vitro models involving cultured PTC do not adequately reproduce
the loss of cell viability found in vivo. In this connection, it should be also noted the limitations
of cultured HK-2 cells in particular and of 2-dimension (2D) proximal tubular cell culture in
general as models of the proximal tubule. Thus, many of the available model cell lines fail to
replicate the differential expression of several uptake and efflux membrane transporters and
metabolizing enzymes, which is one of the characteristics of native PTC [71]. Another major
shortcoming of PTC culture is the use of metabolic fuels as compared to native proximal
tubules: these reabsorb the filtered glucose and are gluconeogenic, but to drive their energy
needs, native PTC rely physiologically on oxidative metabolism rather than glycolysis [72–74].
However, when PTC are brought into tissue culture, they revert from oxidative metabolism
and gluconeogenesis to high rates of glycolysis. In the case of HK-2 cells, our current results
and previous reports [42, 75–77], indicate that they have glycolytic and gluconeogenic activi-
ties. Interestingly, in DKD [30] and other pathological conditions, proximal tubule glycolytic
flux plays an important pathogenic role [73, 78, 79, 80], which suggests that our results on gly-
colytic enzymes in HK-2 cells exposed to the diabetic-like milieu might be pathologically rele-
vant. However, specific studies in native proximal tubules should confirm this hypothesis. On
the other hand, it is important to note that our model has been specifically conceived to moni-
tor the effects over time of HG and hypoxia on the protein expression in HK-2 cells and, there-
fore, we refer to these conditions (25 mM glucose/1% O2) as “diabetic-like”
microenvironment rather than diabetic microenvironment because the latter is much more
complex [5]. Besides, the very large and rapid time changes in glucose and O2 utilized here are
far from being physiologic (or even pathologic, excepting in sudden vascular occlusion) and
25 mM glucose is higher than the plasma glucose concentration in most diabetic patients,
whereas it is not known whether 1% O2 is the actual degree of hypoxia to which PTC are
exposed in the kidneys of the diabetic patients. Furthermore, due to poor penetration of O2
through the medium, the pericellular concentration of O2 in cells grown in culture under
atmospheric air may reach the hypoxic range [81]. On the other hand, short term exposure to
HG/hypoxia may not reveal all the long-term proteomic alterations in PTC during diabetes, as
suggested by our results on the expression of extracellular matrix proteins. Besides these limi-
tations, the novelty of the present study resides on the use of a relatively simple in vitro model
that when simultaneously exposed to hyperglycemia and hypoxia, but not exposed separately
to either condition, show functional alterations that reproduce important changes induced by
diabetes at the renal level in: i) the expression of glucose metabolizing enzymes ii) STAT1 and
HSPs and iii) cytoskeletal-related proteins. Because of that, we believe that this model could be
used as a previous step before the use of expensive in vivo assays.
In summary, the model we have used allows for a detailed study of the proteomic alterations
induced by HG/hypoxia (i.e. two major conditions of the microenvironment that surrounds
PTC in diabetes) in HK-2 cells, which may help to identify new mechanisms and targets to be
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investigated in the future for a better understanding of DKD. But the model has several limita-
tions when compared with the in vivo situation in which native PTC are exposed to the real
diabetic environment and therefore further studies in renal samples from diabetic patients or
from animal models of diabetes are also required to have a better representation of the proteo-
mic changes induced in PTC by the diabetic milieu.
Conclusion
This is the first time-series proteomic study based on DML and UHPLC-MS/MS technology
carried out to analyse the early effects of the diabetic milieu on proximal tubular cells using a
model very simplified of the diabetic microambient (i.e. HG and hypoxia) that surrounds
proximal tubules in diabetes. The combined exposure to HG and hypoxia conditions increased
the percentage of HK-2 dead cells after 24 h without affecting the protein/cell ratio, and it sig-
nificantly altered the expression of different proteins in a time-dependent manner. Several of
these proteins are involved in the glycolysis pathway and their expression control seems to be
HIF-1α-independent. Moreover, the abundancy of other proteins involved in the refolding of
denatured proteins (HSP105 and HSP70) was also increased with time, which might be a coor-
dinated response against the cellular stress imposed by the conditions used. On the other
hand, the expression of different enzymes involved in the oxidative phosphorylation mecha-
nism and the generation of ATP (SLC25A5, ATP5B, ATP5A1) was decreased with time,
reflecting a mitochondrial dysfunction that could contribute to the development of DKD.
Finally, the time expression profile showed a decrease in the expression of ten cytoskeletal-
related proteins (CNN2, TPM1, STMN1 and MYH9 being reported for the first time in con-
nection with DKD), which might be associated to renal fibrosis, but further studies are needed
to connect these changes with fibrosis. With the limitations inherent to the very simplified
model of the diabetic microenvironment that surrounds proximal tubules in diabetes, the pres-
ent proteomic study suggests new mechanisms and targets to be investigated in proximal tubu-
lar cells in the context of the pathogenesis of DKD.
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Liquid Chromatography-Mass Spectrometry for Exploratory Bottom-Up Proteomic Analyses. Anal
Chem 2018; 90:5381–5389. https://doi.org/10.1021/acs.analchem.8b00525 PMID: 29582996
28. Sabatier P, Saei AA, Wang S, Zubarev RA. Dynamic Proteomics Reveals High Plasticity of Cellular Pro-
teome: Growth-Related and Drug-Induced Changes in Cancer Cells are Comparable. Proteomics
2018; 18:e1800118. https://doi.org/10.1002/pmic.201800118 PMID: 30382632
29. Takiyama Y, Haneda M. Hypoxia in Diabetic Kidneys. BioMed Res Int 2014; 2014:837421. https://doi.
org/10.1155/2014/837421 PMID: 25054148
30. Sas KM, Kayampilly P, Byun J, Nair V, Hinder LM, Hur J, et al. Tissue-specific metabolic reprogram-
ming drives nutrient flux in diabetic complications. JCI Insight 2016; 1:e86976. https://doi.org/10.1172/
jci.insight.86976 PMID: 27699244
31. Qi W, Keenan HA, Li Q, Ishikado A, Kannt A, Sadowski T, et al. Pyruvate kinase M2 activation may pro-
tect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med
2017; 23:753–762. https://doi.org/10.1038/nm.4328 PMID: 28436957
32. Iori E, Millioni R, Puricelli L, Arrigoni G, Lenzini L, Trevisan R, et al. Glycolytic enzyme expression and
pyruvate kinase activity in cultured fibroblasts from type 1 diabetic patients with and without nephropa-
thy. Biochim Biophys Acta 2008; 1782:627–633. https://doi.org/10.1016/j.bbadis.2008.08.012 PMID:
18840520
33. Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K. Transcriptome analysis of
human diabetic kidney disease. Diabetes 2011; 60:2354–2369. https://doi.org/10.2337/db10-1181
PMID: 21752957
34. Fan Y, Yi Z, D’Agati VD, Sun Z, Zhong F, Zhang W, et al. Comparison of Kidney Transcriptomic Profiles
of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progres-
sion. Diabetes 2019; 68:2301–2314. https://doi.org/10.2337/db19-0204 PMID: 31578193
PLOS ONE Time-series proteomic study of the response of HK-2 cells to hyperglycemic, hypoxic diabetic-like milieu
PLOS ONE | https://doi.org/10.1371/journal.pone.0235118 June 24, 2020 18 / 21
35. Tang SC, Leung JC, Chan LY, Cheng AS, Lan HY, Lai KN. Renoprotection by rosiglitazone in acceler-
ated type 2 diabetic nephropathy: Role of STAT1inhibition and nephrin restoration. Am J Nephrol 2010;
32:145–155. https://doi.org/10.1159/000316056 PMID: 20606418
36. Lopez-Sanz L, Bernal S, Recio C, Lazaro I, Oguiza A, Melgar A, et al. SOCS1-targeted therapy amelio-
rates renal and vascular oxidative stress in diabetes via STAT1and PI3K inhibition. Lab Invest 2018;
98:1276–1290. https://doi.org/10.1038/s41374-018-0043-6 PMID: 29540859
37. Chevotareva N, Bobkova I, Shilov E. Heat shock proteins and kidney disease: perspectives of HSP
therapy. Cell Stress Chaperones 2017; 22:319–343. https://doi.org/10.1007/s12192-017-0790-0 PMID:
28409327
38. Yamagishi N, Yokota M, Yasuda K, Saito Y, Nagata K, Hatayama T. Characterization of stress sensitiv-
ity and chaperone activity of Hsp105 in mammalian cells. Biochem Biophys Res Commun 2011;
409:90–95. https://doi.org/10.1016/j.bbrc.2011.04.114 PMID: 21557931
39. Higgins GC, Coughlan MT. Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic
nephropathy? Br J Pharmacol 2014; 171:1917–1942. https://doi.org/10.1111/bph.12503 PMID:
24720258
40. Guan SS, Sheu ML, Wu CT, Chiang CK, Liu SH. ATP synthase subunit-β down-regulation aggravates
diabetic nephropathy. Sci Rep 2015; 5:14561. https://doi.org/10.1038/srep14561 PMID: 26449648
41. Chevrollier A, Loiseau D, Reynier P, Stepien G. Adenine nucleotide translocase 2 is a key mitochondrial
protein in cancer metabolism. Biochim Biophys Acta 2011; 1807:562–567. https://doi.org/10.1016/j.
bbabio.2010.10.008 PMID: 20950584
42. Czajka A, Malik AN. Hyperglycemia induced damage to mitochondrial respiration in renal mesangial
and tubular cells: Implications for diabetic nephropathy. Redox Biol 2016; 10:100–107. https://doi.org/
10.1016/j.redox.2016.09.007 PMID: 27710853
43. Munusamy S, MacMillan-Crow LA. Mitochondrial superoxide plays a crucial role in the development
of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells. Free
Radic Biol Med 2009; 46:1149–1157. https://doi.org/10.1016/j.freeradbiomed.2009.01.022 PMID:
19439219
44. So EJ, Kim HJ, Kim CW. Proteomic analysis of human proximal tubular cells exposed to high glucose
concentrations. Proteomics Clin Appl 2008; 2:1118–1126. https://doi.org/10.1002/prca.200780151
PMID: 21136909
45. Magri CJ, Fava S. The role of tubular injury in diabetic nephropathy. Eur J Intern Med 2009; 20:551–
555. https://doi.org/10.1016/j.ejim.2008.12.012 PMID: 19782912
46. Bera A, Das F, Ghosh-Choudhury N, Mariappan MM, Kasinath BS, Ghosh Choudhury G. Reciprocal
regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal
tubular epithelial cell hypertrophy and matrix expansion. Am J Physiol-Cell Physiol 2017; 313:C430–
C447. https://doi.org/10.1152/ajpcell.00081.2017 PMID: 28701356
47. Vallon V, Komers R. Pathophysiology of the diabetic kidney. Compr Physiol 2011; 1:1175–1232.
https://doi.org/10.1002/cphy.c100049 PMID: 23733640
48. Parrish AR. The cytoskeleton as a novel target for treatment of renal fibrosis. Pharmacol Ther 2016;
166:1–8. https://doi.org/10.1016/j.pharmthera.2016.06.006 PMID: 27343756
49. Belletti B, Baldassarre G. Stathmin: a protein with many tasks. New biomarker and potential target in
cancer. Expert Opin Ther Targets 2011; 15:1249–1266. https://doi.org/10.1517/14728222.2011.
620951 PMID: 21978024
50. Zahedi K, Revelo MP, Barone S, Wang Z, Tehrani K, Citron DP, et al. Stathmin-deficient mice develop
fibrosis and show delayed recovery from ischemic-reperfusion injury. Am J Physiol-Renal Physiol 2006;
290:F1559–F1567. https://doi.org/10.1152/ajprenal.00424.2005 PMID: 16434570
51. Liu T, Liu L, Liu M, Du R, Dang Y, Bai M, et al. MicroRNA-493 targets STMN-1 and promotes hypoxia-
induced epithelial cell cycle arrest in G2/M and renal fibrosis. FASEB J 2019; 33:1565–1577. https://doi.
org/10.1096/fj.201701355RR PMID: 30183377
52. Sanders MC, Goldstein AL, Wang YL. Thymosin beta 4 (Fx peptide) is a potent regulator of actin poly-
merization in living cells. Proc Natl Acad Sci USA 1992; 89:4678–4682. https://doi.org/10.1073/pnas.
89.10.4678 PMID: 1584803
53. Zhu J, Su LP, Zhou Y, Ye L, Lee KO, Ma JH. Thymosin beta4 attenuates early diabetic nephropathy in
a mouse model of type 2 diabetes mellitus. Am J Ther 2015; 22:141–146. https://doi.org/10.1097/MJT.
0b013e3182785ecc PMID: 23846524
54. Kumar N, Liao TD, Romero CA, Maheshwari M, Peterson EL, Carretero OA. Thymosin β4 Deficiency
Exacerbates Renal and Cardiac Injury in Angiotensin-II-Induced Hypertension. Hypertension. 2018;
71:1133–1142. https://doi.org/10.1161/HYPERTENSIONAHA.118.10952 PMID: 29632102
PLOS ONE Time-series proteomic study of the response of HK-2 cells to hyperglycemic, hypoxic diabetic-like milieu
PLOS ONE | https://doi.org/10.1371/journal.pone.0235118 June 24, 2020 19 / 21
55. Yuan J, Shen Y, Yang X, Xie Y, Lin X, Zeng W, et al. Thymosin β4 alleviates renal fibrosis and tubular
cell apoptosis through TGF-β pathway inhibition in UUO rat models. BMC Nephrol 2017; 18:314.
https://doi.org/10.1186/s12882-017-0708-1 PMID: 29047363
56. Thelen S, Abouhamed M, Ciarimboli G, Edemir B, Bähler M. Rho GAP myosin IXa is a regulator of kid-
ney tubule function. Am J Physiol-Renal Physiol 2015; 309:F501–F513. https://doi.org/10.1152/
ajprenal.00220.2014 PMID: 26136556
57. Fehon RG, McClatchey AI, Bretscher A. Organizing the cell cortex: the role of ERM proteins. Nat Rev
Mol Cell Biol 2010; 11:276–287. https://doi.org/10.1038/nrm2866 PMID: 20308985
58. Sun YM, Su Y, Li J, Wang LF. Recent advances in understanding the biochemical and molecular mech-
anism of diabetic nephropathy. Biochem Biophys Res Commun 2013; 433:359–361. https://doi.org/10.
1016/j.bbrc.2013.02.120 PMID: 23541575
59. Gallicchio MA, Bach LA. Uptake of advanced glycation end products by proximal tubule. Epithelial cells
via macropinocytosis. Biochim Biophys Acta 2013; 1833:2922–2933. https://doi.org/10.1016/j.bbamcr.
2013.05.024 PMID: 23747564
60. Kuwagata S, Kume S, Chin-Kanasaki M, Araki H, Araki S, Nakazawa J, et al. MicroRNA148b-3p inhibits
mTORC1-dependent apoptosis in diabetes by repressing TNFR2 in proximal tubular cells. Kidney Int
2016; 90:1211–1225. https://doi.org/10.1016/j.kint.2016.06.036 PMID: 27591086
61. Brezniceanu ML, Liu F, Wei CC, Chénier I, Godin N, Zhang SL, et al. Attenuation of Interstitial Fibrosis
and Tubular Apoptosis in db/db Transgenic Mice Overexpressing Catalase in Renal Proximal Tubular
Cells. Diabetes 2008; 57:451–459. https://doi.org/10.2337/db07-0013 PMID: 17977949
62. Kumar D, Zimpelmann J, Robertson S, Burns KD. Tubular and interstitial cell apoptosis in the streptozo-
tocin-diabetic rat kidney. Nephron Exp Nephrol 2004; 96:e77–e88. https://doi.org/10.1159/000076749
PMID: 15056984
63. Kumar D, Robertson S, Burns KD. Evidence of apoptosis in human diabetic kidney. Mol Cell Biochem
2004; 259:67–70. https://doi.org/10.1023/b:mcbi.0000021346.03260.7e PMID: 15124909
64. Zhang X, Guan T, Yang B, Chi Z, Wan Q, Gu HF. Protective effect of berberine on high glucose and
hypoxia-induced apoptosis via the modulation of HIF-1α in renal tubular epithelial cells. Am J Transl
Res 2019; 11:669–682. PMID: 30899370
65. Wang J, Guo HM. Astragaloside IV ameliorates high glucose-induced HK-2 cell apoptosis and oxidative
stress by regulating the Nrf2/ARE signaling pathway. Exp Ther Med 2019; 17:4409–4416. https://doi.
org/10.3892/etm.2019.7495 PMID: 31086575
66. Huang YF, Zhang Y, Liu CX, Huang J, Ding GH. microRNA-125b contributes to high glucose-induced
reactive oxygen species generation and apoptosis in HK-2 renal tubular epithelial cells by targeting
angiotensin-converting enzyme 2. Eur Rev Med Pharmacol Sci 2016; 20:4055–4062. PMID: 27775793
67. Guo C, Li Y, Zhang R, Zhang Y, Zhao J, Yao J, et al. Protective Effect of Salidroside Against Diabetic
Kidney Disease Through Inhibiting BIM-Mediated Apoptosis of Proximal Renal Tubular Cells in Rats.
Front Pharmacol 2018; 9:1433. https://doi.org/10.3389/fphar.2018.01433 PMID: 30564128
68. Li M, Khan AM, Maderdrut JL, Simon EE, Batuman V. The Effect of PACAP38 on MyD88-Mediated Sig-
nal Transduction in Ischemia-/Hypoxia-Induced Acute Kidney Injury. Am J Nephrol 2010; 32:522–532.
https://doi.org/10.1159/000321491 PMID: 20980738
69. Mimura I, Hirakawa Y, Kanki Y, Kushida N, Nakaki R, Suzuki Y, et al. Novel lnc RNA regulated by HIF-1
inhibits apoptotic cell death in the renal tubular epithelial cells under hypoxia. Physiol Rep 2017; 5:
e13203. https://doi.org/10.14814/phy2.13203 PMID: 28420760
70. Tanaka T, Hanafusa N, Ingelfinger JR, Ohse T, Fujita T, Nangaku M. Hypoxia induces apoptosis in
SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-medi-
ated upregulation of Bax. Biochem Biophys Res Commun 2003; 309:222–231. https://doi.org/10.1016/
s0006-291x(03)01557-2 PMID: 12943686
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